BI Share Price Target 2035

CAGR-based price projection for Bilcare Limited (BI) targeting 2035, derived from official NSE exchange closing prices.

Bear Case (17.6% CAGR)
Rs 393
2035 Target
Base Case (43.9% CAGR)
Rs 2,424
2035 Target
Bull Case (139.2% CAGR)
Rs 234,701
2035 Target

Current Market Snapshot

CMP: Rs 91.66
52W High: Rs 101.38
52W Low: Rs 56.18
1Y CAGR: 107.1%
3Y CAGR: 43.9%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 108 Rs 132 Rs 219
2028 Rs 127 Rs 190 Rs 524
2029 Rs 149 Rs 273 Rs 1,254
2030 Rs 175 Rs 393 Rs 2,999
2031 Rs 206 Rs 565 Rs 7,173
2032 Rs 242 Rs 814 Rs 17,156
2033 Rs 284 Rs 1,171 Rs 41,031
2034 Rs 334 Rs 1,685 Rs 98,132
2035 Rs 393 Rs 2,424 Rs 234,701

Other BI Price Targets

2025 2026 2027 2028 2030 2040 2050

Frequently Asked Questions

What is the BI share price target for 2035?

Based on historical growth analysis, the BI share price target for 2035 ranges from Rs 393 (conservative) to Rs 2,424 (base case) to Rs 234,701 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of BI?

The current market price of BI (Bilcare Limited) is Rs 91.66. The 52-week high is Rs 101.38 and 52-week low is Rs 56.18.

Is BI a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for BI price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 17.6% CAGR), Base (43.9% CAGR), and Bull (optimistic at 139.2% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.